Mechanism of Action
Understanding pluripotency without tumorigenic risk.
Join a member of our team for an exclusive deep dive into MuseMSCs. Discover the breakthrough mechanisms driving the next generation of clinical therapeutics and how offering MuseMSCs™ can elevate your practice and help your patients recover faster.
Understanding pluripotency without tumorigenic risk.
Reviewing outcomes in recent advanced trials.
How Muse cells target damaged tissue dynamically.
Kyle Cetrulo
Fouder & CEO, StemCell Athlete, LLC.
JUNE 17th • 1:00 PM EST/10 AM PST
By registering, you agree to our privacy policy.